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Abstract
Objective: To assess the general practitioners (GP) knowledge regarding the diagnosis and initial drug therapy
for acute myocardial infarction (AMI).
Methods:  A questionnaire-based survey was conducted in randomly selected GPs of Karachi. Doctors working
in community as GPs who were registered medical practitioners having a Bachelor of Medicine & Bachelor of
Surgery degree were included in the study. Doctors working at tertiary care facilities or having a post graduate
degree or post graduate training in a specialty other than family medicine were excluded from the study.
Results:  A total of 186 GPs participated in our study. GPs who studied research journals were 2.33 times more
likely to investigate serum cardiac troponins levels for the diagnosis of AMI compared to those who did not study
research journals (P = 0.02). Twenty six percent of the GPs said that they would refer a patient with suspected
AMI without treatment, while 76% said that they would consider some treatment prior to referral. Fifty eight
percent of the GPs identified ST segment elevation myocardial infarction (STEMI) of <12 hours duration as an
indication of thrombolysis while 28% identified posterior wall AMI as a thrombolytic indication.
Conclusion: GPs, although adequately aware of the presenting features of AMI, were lacking in knowledge
regarding the means for confirmation of diagnosis, initial drug therapy and were less likely to carry management
steps in their practice (JPMA 59:118; 2009).
Introduction
Coronary Artery Disease (CAD) has become a leading
contributor to morbidity and mortality in most countries.1 Its
rise of epidemic proportions in the developed countries has been
well documented.2 But the emergence of this epidemic in the
developing countries during the past two to three decades has
attracted lesser comment and public health response, even
within the healthcare enterprises of these nations. It is not
commonly realized that at present, the developing countries
contribute a greater share to the global burden of CAD than the
developed countries.1 Although this high burden of CAD deaths
in itself warrants attention, a greater cause for concern is the
early age of CAD deaths and the projected rise in CAD
mortality rates in the developing world over the next 25 years.3
The majority of patients in Pakistan present to their local
General Practitioner (GP) for most medical complaints.4 Patients
prefer GPs as they are easily accessible and probably because of
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continuity of care. For much of the population, GPs form a vital
triage point for medical emergencies such as acute myocardial
infarction (AMI). Thus, it is of the essence that they must be
prompt and accurate in recognition of these cases and
administration of appropriate initial therapy before swift referral. 
Questions regarding GPs' knowledge of the pre-
hospital management have been addressed in the developed
world;5,6 their findings suggested that the management
practices of GPs vis-à-vis AMI were not in cognizance with
national and international guidelines in entirety. In view of
the even more crucial role that GPs in Pakistan play in
determining the initial management and consequently long-
term outcome following an AMI, we aimed to assess their
knowledge of the diagnosis and initial pharmacological
management regarding the same. To our knowledge, no
such study has been published to date from Pakistan.
Methods
Doctors working in the community as GPs who were
registered medical practitioners having a Bachelor of Medicine
& Bachelor of Surgery degree were included in this study.
Doctors working at tertiary care facilities or those having a post
graduate degree or post graduate training in a specialty other
than family medicine were excluded.
The sample size was calculated using Epi Info Version
6 considering a 95% level of confidence, assumed minimum
prevalence of 10% since no study had been done on the target
population, the power of the study being fixed at 80%. Thirty
one GPs were conveniently chosen from each of the six towns
of Karachi that were randomly selected, making a total of 186.
Across sectional survey was carried out, wherein a self reported
questionnaire was administered to the study participants.
Existing literature regarding the diagnosis and
management of AMI and GPs' knowledge regarding AMI was
extensively reviewed. This helped us identify variables for the
development of the questionnaire. Questions were centered on
key aspects of the clinical presentation, diagnosis, and
management of AMI along with the demographic data of the
participants. The questionnaire was pre-tested on 20
conveniently selected GPs, which is >10% of the target
population. Essential alterations were made in the questionnaire
based on the results of the pilot study. Data were analyzed using
SPSS version 13 for Windows. Chi-square test was employed to
test association between various categorical variables. 
The project was reviewed and approved by the Ethical
Review Committee of the Aga Khan University. Informed
written consent was obtained before administering the
questionnaire. Participants' confidentiality was maintained;
names were not asked and data was only available for research
and publication purposes. Additionally, the data obtained were
grouped before being subjected to analysis as against analyzing
individuals separately.
Results
Atotal of 186 GPs participated in our study. Out of these
119 (64%) were males and 67 (36%) were females. Thirty
percent of the respondents had attended a seminar, symposium
or workshop on the diagnosis and management of AMI in the
six months immediately preceding this study.
Table 1 illustrates the classic symptoms and
Electrocardiographic (ECG) changes suggestive of AMI
identified by the respondents 
In reply to the question, "what is silent myocardial
infarction (SMI)?" 92% of the respondents chose AMI with no
chest pain, 4.8% chose chest pain due to non-cardiac causes
while the remaining 3.2% chose AMI that made a patient silent.
Eighty four percent of the GPs stated that diabetics were more
likely to get SMI. Twenty-eight perccent said hypertensives
were more likely while another 20% stated that patients with a
past history of AMI were more likely to get an SMI.
Figure 1 illustrates the lab tests essential for establishing the
diagnosis of AMI identified by the respondents. GPs who studied
research journals were 2.33 times more likely to investigate cardiac
troponins levels in the serum for the diagnosis of AMI compared to
those who did not study research journals (P = 0.02). 
Twenty six percent of the GPs said that they would refer
a patient with suspected AMI without treatment, while 76% said
that they would consider some treatment prior to referral.
Nitroglycerine and Asprin were the two most commonly
considered medications before referral. Female GPs were four
Table 1: Symptoms and ECG changes suggestive of AMI identified by the respondents.
Symptoms of AMI identified by the respondents ECG changes suggestive of AMI identified by the respondents
Number of GPs %age of total Number of GPs %age of total
Chest pain 186 100 ST Elevation 159 85
Sweating 168 90 ST Depression 84 45
Shortness of breath 145 78 T wave inversion 77 41
Shoulder pain 130 70 Q wave appearance 76 41
Palpitations 108 58 New onset bundle branch block 44 24
Weakness/ Dizziness 71 38 P wave inversion 17 9
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times more likely to refer a patient with suspected AMI without
treatment compared to male GPs (P < 0.01).
Figure 2 illustrates the differences between knowledge
and practices of GPs regarding initial drug therapy for AMI.
GPs were asked to identify the indications and
contraindications for thrombolysis Fifty eight percent of the
GPs identified ST segment elevation myocardial infarction
(STEMI) of <12 hours duration as an indication of thrombolysis
while 28% identified posterior wall AMI with dominant R
waves and ST depression in leads V1-V3 as an indication. Forty
seven percent of the GPs considered pregnancy as a
contraindication for thrombolysis. 
Sources of GPs' knowledge included: books (87%),
fellow doctors (61%), seminars/ workshops (57%), and
Research Journals (43%). Possible ways identified by GPs to
improve their knowledge were: Seminars/ Symposia/
Workshop (82%), Newspapers and Magazines (40%),
Television (29%), and others, including provision of research
journals and regular exams (4%).
Discussion
GPs demonstrated adequate knowledge of the
presenting features of AMI. Such patients usually present
with chest pain, shortness of breath, sweating, and
palpitations.7,8 Respondents in our study largely identified
these presenting symptoms. A good majority of GPs also
knew about silent MI, and also that diabetics were more
likely to get it. 
Serum Cardiac troponins (cTnI, cTnT) are a gold
standard for the diagnosis of AMI and have been
recommended as an essential component in the recent re-
definition of AMI by The Joint European Society of
Cardiology/ American College of Cardiology Committee.9 In
our study, however, one fourth of the GPs did not consider
serum troponin levels as an essential test for the diagnosis of
AMI. A significant difference existed in knowledge about
cardiac enzymes between GPs who used research journals as
a knowledge source and those who did not, suggesting that
readers of research publications are better aware of the
advancements in knowledge about AMI. 
ECG remains a fundamental tool in the diagnosis and
management of AMI. An analysis of ECG patterns helps
implicate the infarct-related artery, predicts the amount of
myocardium at risk and recognizes new conduction
abnormalities and arrhythmias, which in turn influence
decisions regarding the use of reperfusion therapy.10 In our
study, an encouraging number (97.3%) of GPs considered
ECG as an essential test to diagnose AMI. But the deficiencies
in knowledge about the proper interpretation of ECG are
alarming. The fact that 15% of the respondents did not know
that AMI could be a cause for ST elevation is concerning
because these patients can definitely benefit from timely
reperfusion. ST segment depression (STD) can represent
subendocardial ischaemia and infarcts or frank posterior wall
infarctions.7 But, disappointingly, more than half of our
respondents did not know that STD could be a manifestation of
AMI. An even lower number of GPs knew that newly
appearing Q waves and new onset conduction abnormalities on
ECG could be an indication of AMI. 
This lack of knowledge about ECG interpretation is
not limited to our population of GPs. Studies performed on
family medicine residents in the United States and United
Arab Emirates have also demonstrated a suboptimal
knowledge suggesting that difficulty in ECG interpretation
transcends geographic boundaries.11,12
According to the British Heart Foundation's
guidelines for early management of patients with AMI, the
role of the GP includes rapid diagnosis of patients with chest
pain, provision of adequate analgesia, aspirin, GTN and beta-
blockers, initiation of treatment for complications and
expedition of eventual reperfusion therapy.13 A proportional
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Figure 1: Lab tests essential for establishing the Diagnosis of AMI
identified by the respondents.
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reduction in 1-year mortality of 22% has been calculated for
acute coronary syndrome when the guidelines are followed.14
About a quarter of the respondents in our study stated
that they would consider referral without giving any treatment
in a cost of suspected AMI. This could be because of the fact
that not all the GPs have ECG machines in their clinics and no
therapy could be initiated without evaluating the ECG of the
patient. In such cases it seems more rational a decision to
consider early referral. The questionnaire did not specifically
ask for the availability of ECG machines at the GPs clinics.
Prompt analgesia is essential after a brief assessment
of any patient suspected of having an AMI.  The guidelines
propose that GPs should give opioids intravenously for
analgesia as well as for their anxiolytic effect.13 Studies
have advocated the need for morphine administration in
patients with suspected or definite AMI.15,16 Although many
GPs (78%) in our study identified morphine as part of the
initial management of AMI, less than half said that they
would actually prescribe it in a suspected case of AMI. This
discrepancy could be because of the fact that GPs in Karachi
are unlikely to have morphine in their clinics for use.
The role of aspirin in the management of suspected
AMI has been well established.17,18 The GP is in an ideal
position to administer this clearly beneficial therapy to the
patients. According to a Sri Lankan study, few patients with
AMI had been given early aspirin therapy. Only a minority of
GPs were aware of the benefits of early aspirin therapy in
AMI, and very few prescribed it.19 Moher et al noted that
only one fifth of patients presenting with acute chest pain
received aspirin before admission.20 All these findings are
consistent with our results which exhibit sub optimal
utilization of aspirin despite adequate knowledge.
The early use of beta blockers in acute MI is associated
with a reduced risk of re-infarction and ventricular fibrillation but
an increased risk of cardiogenic shock.21 Despite this proven
cardioprotective effect, a considerable number of our study
participants were not aware of its use and an even smaller number
prescribed it. These results are in parallel with the findings of John
Z et al who found only 51% of the family physicians to be aware
of the benefits of beta-blockers in cases of AMI.5
Various studies have shown that thrombolysis
initiated by GPs showed clear and significant reductions in
both mortality and markers of left ventricular damage.22-24
Hannaford et al showed that GPs can use anistreplase both
appropriately and safely in the early management of AMI.25
A survey by Round A et al suggests that GPs, although well
informed about it, do not wish to administer thrombolysis
themselves.6 We observed a similar discrepancy in the
knowledge (62%) and practices (14.5%) of our study
population regarding thrombolytic therapy. An important
reason for this is that GP's clinics in Karachi may not be
appropriately equipped to initiate treatments like
thrombolysis. Under such circumstances timely referral to a
hospital may be the only way to save lives. Furthermore, the
inaccurate knowledge regarding its indications and
contraindications could mean that a substantial number of
patients who could benefit from thrombolysis may not be
administered thrombolytics or referred for it.
Conclusions
In light of the observations made in our study, it
becomes apparent that GPs are lacking adequate knowledge
regarding some crucial aspects of AMI diagnosis and initial
drug therapy. This is alarming because timely identification
and administration of appropriate initial treatment determines
the morbidity and mortality associated with AMI.
We recommend that educational activities like
seminars, symposia, and workshops should be organized on a
regular basis in order to improve and update GPs' knowledge
about AMI. We also advise that all future seminars and CME
sessions be organized with the aim of maximizing female GP
participation as their knowledge was significantly lower in
some crucial areas such as the decision to institute initial
therapy before referral in the setting of an AMI. Furthermore,
our study showed that GPs who read medical journals were
better aware of the recent developments regarding AMI.
Hence, it is suggested that relevant articles from leading
research journals should be made available to all GPs.
References
1. Lopez AD. Assessing the burden of mortality from cardiovascular disease. World
Health Stat Q 1993; 46:91-6. 
2. Beaglehole R. Global cardiovascular disease prevention: time to get serious. Lancet
2001; 358:661-3.
3. Sans S, Puigdefa 'bregas A, Paluzie G, Monterde D, Balaguer-Vintro I. Increasing
trends of acute myocardial infarction in Spain: the MONICA-Catalonia Study. Eur
Heart J 2005; 26: 505-15.
4. Raghavan R, Ramhe E, Nedjar H, Huynh T. Long term prognosis of South Asians
following acute coronary syndromes. Can J Cardiol 2008; 24: 585-7.
5. Pearson TA, Jamison DT, Tergo-Gauderies J. Cardiovascular disease. In: Jamison
DT, Mosley WH, eds. Disease Control Priorities in Developing Countries. New
York, NY: Oxford University Press, 1993; pp 577-99.
6. Shahpurwala MM, Sani N, Shah S, Shuja F, Shahid K, Tariq H, et al. General
medical practitioners in Pakistan fail to educate patients adequately about
complications of diabetes. Practical Diabetes International 2006; 23: 57-61.
7. Rakel RE. Textbook of Family Practice. 6th edi. Philadelphia WB Saunders Co.
Elsevier, 2002.
8. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ.
Knowledge and Practices of Generalist and Specialist Physicians Regarding Drug
Therapy for Acute Myocardial Infarction. N Engl J Med 1994; 331:1136-42.
9. Round A, Marshall AJ. Survey of general practitioners' prehospital management of
suspected acute myocardial infarction. BMJ 1994; 309: 375-6.
10. Kasper DL, Braunwald E, Fauci A, Hauser S, Longo D, Jameson JL. Harrison's
Principles of Internal Medicine; 16th edi. Vol 1. McGraw-Hill Professional,
Philadelphia 2004; 1267-69.
11. Stiefelhagen P. Chest pain, acute dyspnea, palpitations: internistic emergencies
mandate prompt and appropriate action. MMW Fortschr Med 2006; 148(27-
28):24-8.
12. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a
consensus document of The Joint European Society of Cardiology/American
Vol. 59, No. 2, February 2009 122
College of Cardiology Committee for the redefinition of myocardial infarction. J
Am Coll Cardiol 2000; 36:959-69.
13. Zimetbaum PJ, Josephson ME. Use of the electrocardiogram in acute myocardial
infarction. N Engl J Med 2003; 348: 933-40.
14. Margolis S, Reed R. EKG analysis skills of family practice residents in the United
Arab Emirates: a comparison with US data. Fam Med 2001; 33:447-52.
15. Sur DK, Kaye L, Mikus M, Goad J, Morena A.Accuracy of electrocardiogram
reading by family practice residents. Fam Med 2000; 32: 315-9.
16. Weston CF, Penny WJ, Julian DG. Guidelines for the early management of patients
with myocardial infarction. BMJ 1994; 308:767-71.
17. Alexander KP, Peterson ED, Granger CB, Casas AC, Van de Werf F, Armstrong
PW, et al. Potential impact of evidence-based medicine in acute coronary
syndromes: insights from GUSTO IIb. Global Use of Strategies to Open Occluded
Arteries in Acute Coronary Syndromes trial. J Am Coll Cardiol 1998; 32: 2023-30.
18. Everts B, Karlson BW, Herlitz J, Hedner T. Morphine use and pharmacokinetics in
patients with chest pain due to suspected or definite acute myocardial infarction.
Eur J Pain 1998; 2:115-25.
19. Schiff JH, Arntz HR, Bottiger BW. Acute coronary syndrome in the prehospital
phase. Anaesthesist 2005; 54:957-74.
20. No authors listed. Secondary prevention of vascular disease by prolonged
antiplatelet treatment. Antiplatelet Trialists' Collaboration. Br Med J (Clin Res
Ed) 1988; 296: 320-31. 
21. No authors listed. ISIS-2 (Second International Study of Infarct Survival)
Collaborative Group. Randomised trial of intravenous streptokinase, oral
aspirin, both, or neither among 17,187 cases of suspected acute myocardial
infarction: ISIS-2. Lancet 1988; 2:349-60.
22. Seneviratne SL, Gunatilake SB, de Silva HJ. Use of early aspirin in suspected
acute myocardial infarction by General Practitioners in Sri Lanka. Int J
Cardiol 1997; 58:171-3.
23. Moher M, Johnson N. Use of aspirin by general practitioners in suspected acute
myocardial infarction. BMJ 1994; 308:760.
24. Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, et al. COMMIT
(ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group.
Early intravenous then oral metoprolol in 45,852 patients with acute myocardial
infarction: randomised placebo-controlled trial. Lancet 2005; 366:1622-32.
25. No authors listed. Feasibility, safety and efficacy of domiciliary thrombolysis by general
practitioners: Grampian region early trial. GREAT Group. BMJ 1992; 305:548-53.
26. Pre-hospital thrombolytic therapy in patients with suspected acute myocardial
infarction. The European Myocardial Infarction Group. N Engl J Med 1993;
329: 383-9.
27. Weaver WD, Cerqueira M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, et
al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial
Infarction Triage and Intervention Trial. JAMA 1993; 270:1211-6.
28. Hannaford P, Vincent R, Ferry S, Hirsch S, Kay C. Assessment of the practicality
and safety of thrombolysis with anistreplase given by general practitioners. Br J
Gen Pract 1995; 45:175-9.
Students’ Corner
Letter to the Editor
Calcium Supplementation in Postmenopausal Women: Rethinking the Prescription
Madam, Maintaining calcium homeostasis is
imperative for optimal bone health. This mineral
equilibrium in the body is achieved through an intricate
interplay of hormones. The years leading up to menopause
are the harbinger of an estrogen deficient state in the body
of a female. This translates into important implications for
bone health; placing postmenopausal women at a higher
risk of fragility fractures because of osteoporosis.
The Pakistani populace is observed to be Vitamin
D deficient and hypocalcaemic; this trend being
observed even among individuals of a younger
demographic distribution. Women have generally shown
a more severe deficiency than men.1 In view of the
widespread calcium deficiency prevalent among the
population, it has become a common practice to
uniformly prescribe calcium to postmenopausal women
for the prevention of osteoporosis in pursuit of universal
recommendations of the same. 
While calcium has been shown to be an effective
treatment for osteoporosis in people over the age of 50
years2 and current guidelines for calcium intake recommend
an amount of 1200 mg per day for such individuals as well,
new emerging evidence incriminates calcium as a culprit in
increasing cardiovascular morbidity and mortality in
postmenopausal women.3,4 One recent randomized
controlled trial reported a statistically significant increase in
myocardial infarction in the calcium group (p=0.047).5
While these studies maybe fraught with some limitations
and their results are not wholly unequivocal, they raise
some concern about the safety profile of calcium
supplementation in this age group. Meticulous risk
assessment before starting calcium supplementation could
therefore be advocated on the grounds that the importance
of the deleterious effects of calcium supplementation on
cardiovascular disease burden in postmenopausal women
could parallel its beneficial effects on bone in these
women.5 This holds immense relevance in our context
because cardiovascular diseases form one of major slices of
the disease burden of Pakistan. 
Future studies are required to validate these findings
in our setting as this new evidence places us on the horns of
a dilemma. We must carefully locate the fulcrum where we
are able to weigh the burden of cardiovascular diseases vis
a vis osteoporotic fractures; the former now conjectured to
have a link to widely and often indiscriminately prescribed
calcium supplementation. 
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